Literature DB >> 2651533

Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.

M Jacewicz1, H A Feldman, A Donohue-Rolfe, K A Balasubramanian, G T Keusch.   

Abstract

Binding kinetics of Shiga toxin to HeLa CCL-2 cells and to cell lines cloned by limiting dilutions were determined. Lines with a wide range of sensitivity to Shiga toxin were obtained. Binding data, analyzed by a computer-based Scatchard model program, revealed two classes of binding sites, one of low affinity and high capacity and one of high affinity and low capacity. The number of high affinity, but not low affinity, sites present on the clones correlated with their sensitivity to toxin. Tunicamycin-treated CCL-2 cells became resistant to Shiga toxin in parallel with a reduction in the capacity of the high-affinity site. Cell content of Gb3, the glycolipid receptor for Shiga toxin, decreased as the sensitivity of the cells diminished. These data show that a minority of Shiga toxin binding sites of HeLa cells are involved in the cytotoxic response and suggest that Gb3 is the high-affinity functional cytotoxin receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651533     DOI: 10.1093/infdis/159.5.881

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.

Authors:  M Abul-Milh; Y Wu; B Lau; C A Lingwood; D Barnett Foster
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.

Authors:  K Ramotar; B Boyd; G Tyrrell; J Gariepy; C Lingwood; J Brunton
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

3.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.

Authors:  J E Samuel; L P Perera; S Ward; A D O'Brien; V Ginsburg; H C Krivan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

4.  Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Authors:  C M Thorpe; B P Hurley; L L Lincicome; M S Jacewicz; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression.

Authors:  C M Thorpe; W E Smith; B P Hurley; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.

Authors:  Beth Binnington; Daniel Lingwood; Anita Nutikka; Clifford A Lingwood
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2.

Authors:  Michael J Flagler; Sujit S Mahajan; Ashish A Kulkarni; Suri S Iyer; Alison A Weiss
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

8.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.

Authors:  V L Tesh; B Ramegowda; J E Samuel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.

Authors:  B Ramegowda; V L Tesh
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells.

Authors:  D Johansson; C Andersson; J Moharer; A Johansson; P Behnam-Motlagh
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.